Overview

Study of TNF-Antagonism in Metabolic Syndrome

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
This study investigates whether blockade of TNF will result in reduced inflammatory indices in patients with the metabolic syndrome
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Amgen
Treatments:
Etanercept